Parameters   PTPRδ rs17584499A
  CC (n=23) CT+TT (n=21) P value
Sex(F/M) 18(5) 15(6) 0.601
BMI (kg/m2) -1.69 ± 1.99 -0.81 ± 1.92 0.143
FPG (mmol/L) -2.17 ± 2.36 -3.56 ± 4.18 0.177
PPG (mmol/L) -5.68 ± 4.38 -8.78 ± 5.72 0.049 *
FINS (mU/L) 5.68 ± 5.99 4.90 ± 4.81 0.637
PINS (mU/L) -16.40 ± 8.87 -13.16 ± 29.86 0.667
HOMA-IR 0.57 ± 3.62 -0.27 ± 4.17 0.480
HbAlc(%) -1.08 ± 2.02 -2.86 ± 2.68 0.015*
TG (mmol/L) -1.39 ± 2.58 -1.25 ± 3.23 0.880
CHO (mmol/L) -0.27 ± 1.63 -0.93 ± 1.14 0.023 *
HDL-C (mmol/L) 0.00 ± 0.26 -0.09 ± 0.19 0.214
LDL-C (mmol/L) 0.03 ± 0.75 -0.18 ± 0.85 0.380
Table 4: The comparisons of different values (postaministration minus preadministration) in T2DM patients with different PTPRδ rs17584499 C/T polymorphism before and after metformin treatment (n = 44).